We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
-14.84%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$851M
AUM Growth
-$209M
Cap. Flow
-$45.5M
Cap. Flow %
-5.35%
Top 10 Hldgs %
32.57%
Holding
202
New
58
Increased
31
Reduced
47
Closed
57

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$28.2M
2
TMUS icon
T-Mobile US
TMUS
+$26.9M
3
SBAC icon
SBA Communications
SBAC
+$11.6M
4
UNH icon
UnitedHealth
UNH
+$10.5M
5
ELV icon
Elevance Health
ELV
+$9.82M

Sector Composition

Rank Sector Weight
1 Financials 22.37%
2 Healthcare 20.33%
3 Technology 17.24%
4 Real Estate 11.09%
5 Consumer Discretionary 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
51
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.64M 0.78%
68,217
+28,226
+71% +$3.7M
GWRE icon
52
Guidewire Software
GWRE
$12.2B
$6.45M 0.76%
80,400
CHCT
53
Community Healthcare Trust
CHCT
$420M
$6.26M 0.74%
217,300
GDS icon
54
GDS Holdings
GDS
$6.1B
$6.13M 0.72%
265,300
+67,047
+34% +$1.75M
CI icon
55
Cigna
CI
$76.3B
$6.01M 0.71%
+31,624
New +$6.6M
CORV
56
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$5.91M 0.69%
2,372,224
+232,930
+11% +$775K
LADR
57
Ladder Capital
LADR
$1.21B
$5.77M 0.68%
372,939
-84,477
-18% -$1.43M
ASML icon
58
ASML
ASML
$611B
$5.45M 0.64%
+35,000
New +$5.94M
BMRN icon
59
BioMarin Pharmaceuticals
BMRN
$12.5B
$5.23M 0.61%
61,389
+25,444
+71% +$2.42M
VCYT icon
60
Veracyte
VCYT
$3.23B
$4.99M 0.59%
396,600
+96,600
+32% +$1.14M
TDOC icon
61
Teladoc Health
TDOC
$1.2B
$4.96M 0.58%
100,128
+3,428
+4% +$210K
BBDC icon
62
Barings BDC
BBDC
$914M
$4.4M 0.52%
488,200
+134,500
+38% +$1.33M
ZTS icon
63
Zoetis
ZTS
$30.3B
$4.23M 0.5%
+49,470
New +$4.46M
SCI icon
64
Service Corp International
SCI
$11.1B
$4M 0.47%
99,268
+34,200
+53% +$1.49M
RH icon
65
RH
RH
$2.36B
$3.82M 0.45%
+31,900
New +$3.83M
BZUN
66
Baozun
BZUN
$159M
$3.72M 0.44%
127,200
+105,300
+481% +$3.88M
CSCO icon
67
Cisco
CSCO
$434B
$3.65M 0.43%
84,300
+37,200
+79% +$1.7M
BABA icon
68
Alibaba
BABA
$272B
$3.62M 0.43%
26,390
-2,760
-9% -$408K
EPI icon
69
WisdomTree India Earnings Fund ETF
EPI
$1.95B
$3.57M 0.42%
143,900
-79,800
-36% -$1.86M
BIIB icon
70
Biogen
BIIB
$31.9B
$3.46M 0.41%
11,485
+2,288
+25% +$730K
RA
71
Brookfield Real Assets Income Fund
RA
$662M
$2.97M 0.35%
+155,800
New +$3.24M
PS
72
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$2.83M 0.33%
+120,000
New +$2.77M
HDB icon
73
HDFC Bank
HDB
$116B
$2.77M 0.33%
+106,800
New +$2.52M
KIO
74
KKR Income Opportunities Fund
KIO
$439M
$2.62M 0.31%
183,805
+66,500
+57% +$1.03M
RVT icon
75
Royce Value Trust
RVT
$2.15B
$2.46M 0.29%
+208,900
New +$2.89M

Similar funds

Clough Capital Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Clough Capital Partners held 202 positions worth $851M, down 20% from $1.06B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Clough Capital Partners withdrew a net $45.5M in Q4 2018, closing 57 positions and reducing 47 holdings. Its most notable exit was Kinder Morgan, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Clough Capital Partners opened a new position in Visa worth $27M.

  • Clough Capital Partners's largest Q4 2018 buy was Visa: 204,350 shares worth $27M.
  • Clough Capital Partners added most to Cornerstone Total Return Fund in Q4 2018, an estimated $6.54M increase.
  • Clough Capital Partners's biggest Q4 2018 reduction was JPMorgan Chase, cutting an estimated $15.5M.
  • Clough Capital Partners fully exited Kinder Morgan in Q4 2018, selling an estimated $17M.
  • Clough Capital Partners's ten largest holdings make up 33% of its $851M portfolio in Q4 2018.
  • Clough Capital Partners opened 58 new positions and closed 57 in Q4 2018.
  • Clough Capital Partners's portfolio value fell 20% quarter-over-quarter to $851M.

Based on Clough Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.